ArticleThe International journal of health planning and management2026
Influenza and Human Papillomavirus Vaccine Utilisation in Vulnerable Urban Youth in Edmonton, Alberta, Canada.
Article in The International journal of health planning and management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionThis project explores influenza and human papillomavirus (HPV) vaccine utilisation among a multi-ethnic group of youth (aged 11-23 years) in Edmonton, Alberta, Canada.
methodUsing a cross-sectional design and purposive sampling, influenza vaccine utilisation over 3 years was assessed via questionnaire. Female participants also reported on HPV vaccine utilisation. Multinomial logistic regression was used to explore the factors associated with vaccine utilisation.
resultsIn the project sample, 16.7% of males and 14.7% of females had received the influenza vaccine each year. The lowest rates of influenza vaccination were reported by African/Middle Eastern/Latin American youth (8.3%), Indigenous youth (10.8%), and youth > 18 years (12.6%). For the HPV vaccine, 61.1% of females reported having received all doses, while 21.9% were unvaccinated. Rates of HPV vaccine utilisation were lowest among females of Asian origin, females aged 18-23 years, and females residing in Canada for < 5 years. DISCUSSION: Observed associations between age, ethnicity, and vaccine utilisation in this study highlight potential barriers and warrant further research to inform policymaking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.